logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HER2+ early breast cancer: ASCO guideline update calls for T-DM1 for residual disease

T-DM1 for residual disease in the breast or axilla is the first recommendation.